Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022
Revenue for the year ending December 31, 2022 is expected to be in the range of approximately $1.33 billion to $1.35 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.78 USD | -2.08% | -2.42% | -31.14% |
1st Jan change | Capi. | |
---|---|---|
-31.14% | 2.67B | |
+6.89% | 33.25B | |
+20.58% | 7.96B | |
+34.25% | 4.25B | |
-14.96% | 1.48B | |
-25.64% | 1.28B | |
-30.53% | 1.2B | |
+11.41% | 999M | |
-35.42% | 902M | |
-20.88% | 686M |